Loading...
Acute rosiglitazone treatment during reperfusion after hyperglycemic stroke is neuroprotective not vascular protective
Reperfusion therapy for ischemic stroke can cause secondary brain injury, especially under hyperglycemic (HG) conditions. Here we investigated the effect of acute treatment with rosiglitazone, a peroxisome proliferator-activated receptor-gamma (PPAR-γ) agonist, prior to postischemic reperfusion, on...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3484888/ https://ncbi.nlm.nih.gov/pubmed/23125879 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12975-012-0190-9 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|